Jenkem Technology Soars 10.63% to Intraday High Amid Strong Performance

Jenkem Technology Co., Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock performance, gaining 10.63% on June 29, 2026. The stock reached an intraday high of CNY 80.49, marking a notable achievement in its trading activity for the day. In terms of performance metrics, Jenkem has outperformed the China Shanghai Composite Index, which recorded a modest gain of 1.16% on the same day. Over the past week, Jenkem's stock has surged by 14.84%, contrasting sharply with the Composite's decline of 2.14%. However, the company's year-to-date performance remains negative at -3.77%, while the Composite index has gained 2.65%. Despite the recent gains, Jenkem has faced challenges in long-term growth, with net sales increasing at an annual rate of 8.46% and operating profit declining by 19.63% over the last five years. The company has reported negative results for the last eight consecutive quarters, highlighting ongoing financial pressures. With a market capitalization of CNY 4,134 million, Jenkem continues to navigate a complex financial landscape.